BamSEC and AlphaSense Join Forces
Learn More

BioXcel Therapeutics, Inc. – Material Contracts

OTC: BTAIQ    
Share price (11/5/26): $0.01    
Market cap (11/5/26): $275 thousand
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 1 page Material contract
12/34/56
EX-10.5
from 10-Q 16 pages ​ BioXcel Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.4
from 10-Q 8 pages Independent Director Agreement
12/34/56
EX-10.1
from 8-K 1 page Material contract
12/34/56
EX-10.2
from 8-K 2 pages Holder of Warrants to Purchase Common Stock Issued on March 27, 2024 and November 25, 2024 Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Registered Direct Offering on or About the Date Hereof (The “Offering”) by BioXcel Therapeutics, Inc. (The “Company”) of Its Securities (Collectively, the “Securities”)
12/34/56
EX-10.1
from 8-K 27 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 3 pages Milestone and Retention Bonus Agreement
12/34/56
EX-10.1
from 8-K 27 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 3 pages BioXcel Therapeutics, Inc. Amendment to Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 3 pages BioXcel Therapeutics, Inc. Amendment to Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 3 pages BioXcel Therapeutics, Inc. Amendment to Executive Employment Agreement
12/34/56
EX-10.7
from 10-Q 2 pages Addendum to Executive Employment Agreement
12/34/56
EX-10.6
from 10-Q 2 pages Addendum to Executive Employment Agreement
12/34/56
EX-10.5
from 10-Q 2 pages Addendum to Executive Employment Agreement
12/34/56
EX-10.4
from 10-Q 2 pages Addendum to Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 12 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 6 pages Separation Agreement and General Release
12/34/56
EX-10.1
from 10-Q 5 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) of the Type That the Registrant Customarily and Actually Treats as Confidential. Amendment No. 1 to Commercial Supply Agreement
12/34/56
EX-10.1
from 8-K 30 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 15 pages Non-Compete Agreement
12/34/56